TYRA
Tyra Biosciences Inc

158
Mkt Cap
$1.19B
Volume
587,985.00
52W High
$24.05
52W Low
$6.42
PE Ratio
-12.13
TYRA Fundamentals
Price
$22.81
Prev Close
$22.29
Open
$22.46
50D MA
$16.85
Beta
1.40
Avg. Volume
472,996.16
EPS (Annual)
-$1.51
P/B
4.34
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - Time to Buy?
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - Still a Buy...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Tyra Biosciences, Inc. $TYRA Shares Acquired by Walleye Capital LLC
Walleye Capital LLC lifted its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 163.2% in the second quarter, according to the company in its most recent filing with the...
MarketBeat·4d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Raised to "Hold" at Wall Street Zen
Wall Street Zen raised Tyra Biosciences from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·6d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Down - Here's What Happened
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Down - Should You Sell...
MarketBeat·10d ago
News Placeholder
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer Tyra Biosciences Strengthens Leadership Team...
PR Newswire·11d ago
News Placeholder
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the stock, Marketbeat...
MarketBeat·14d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year High - What's Next?
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High - What's Next...
MarketBeat·15d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Director Robert More Sells 246,871 Shares
Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Robert More sold 246,871 shares of the stock in a transaction on Friday, November 21st. The stock was sold at an average price of...
MarketBeat·15d ago
News Placeholder
Tyra Biosciences (NASDAQ:TYRA) Director Sells $4,999,137.75 in Stock
Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Robert More sold 246,871 shares of the company's stock in a transaction that occurred on Friday, November 21st. The stock was sold at...
MarketBeat·16d ago
News Placeholder
Best Growth Stocks To Follow Today - November 22nd
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Canopy Growth, Tyra Biosciences, and Acadia Realty Trust are the seven Growth stocks to watch today, according to MarketBeat's...
MarketBeat·19d ago

Latest TYRA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.